Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05886868 |
|---|---|
| Brief Title: | Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors |
| First Submitted : | May 24, 2023 |
| First Submitted that Met QC Criteria : | May 24, 2023 |
| First Posted : | June 2, 2023 |
| Last Update Submitted that Met QC Criteria : | November 24, 2023 |
| Last Update Posted : | November 29, 2023 |